![Venkat Thalladi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Venkat Thalladi
Teknisk/Vetenskaplig/F&U Direktör på
PROTAGONIST THERAPEUTICS, INC.
Profil
Venkat Thalladi is Chief Technical Officer & Executive Vice President at Protagonist Therapeutics, Inc. starting in 2026.
Formerly, Dr. Thalladi was Senior VP-Chemistry, Manufacturing & Controls at DICE Therapeutics, Inc. Dr. Thalladi earned a doctorate from the University of Hyderabad.
Aktiva positioner av Venkat Thalladi
| Företag | Position | Start |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-04-01 |
Tidigare kända positioner av Venkat Thalladi
| Företag | Position | Slut |
|---|---|---|
| DICE THER | Verksamhetschef | 2023-08-09 |
Venkat Thalladis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
13
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
University of Hyderabad
 University of Hyderabad Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
